New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Twenty four genetic variants linked to heightened womb cancer risk

Twenty four genetic variants linked to heightened womb cancer risk

byBritish Medical JournalCredit: CC0 Public DomainTwenty four common variations in genes coding for cell growth and death, the processing of oestrogen, and gene control factors may be linked to
World medicine December 13,2023
Twenty four genetic variants linked to heightened womb cancer risk

Twenty four genetic variants linked to heightened womb cancer risk

byBritish Medical JournalCredit: CC0 Public DomainTwenty four common variations in genes coding for cell growth and death, the processing of oestrogen, and gene control factors may be linked to
World medicine December 13,2023
Prostate cancer scanning technique waives the need for pre-imaging biopsy in elderly patients

Prostate cancer scanning technique waives the need for pre-imaging biopsy in elderly patients

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.265371In elderly patients with suspected prostate cancer, a prostate-specific membrane
World medicine December 13,2023
Prostate cancer scanning technique waives the need for pre-imaging biopsy in elderly patients

Prostate cancer scanning technique waives the need for pre-imaging biopsy in elderly patients

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.265371In elderly patients with suspected prostate cancer, a prostate-specific membrane
World medicine December 13,2023
Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

byMary Ann Liebert, IncCredit: CC0 Public DomainA new study has shown that gene therapy to treat one of the most common hereditary disorders, aldehyde dehydrogenase type 2 (ALDH2) deficiency, ma
World medicine December 13,2023
Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

byMary Ann Liebert, IncCredit: CC0 Public DomainA new study has shown that gene therapy to treat one of the most common hereditary disorders, aldehyde dehydrogenase type 2 (ALDH2) deficiency, ma
World medicine December 13,2023
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma

CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D. Credit: MD Anderson Cancer CenterAccording to results from a Phase I/IIa trial at The University of Texas MD Anderson
World medicine December 13,2023
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma

CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D. Credit: MD Anderson Cancer CenterAccording to results from a Phase I/IIa trial at The University of Texas MD Anderson
World medicine December 13,2023
Prostate cancer: The basics every man needs to know

Prostate cancer: The basics every man needs to know

by Miriam Jones Bradley, RNNo man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated.Prostate cancer affects one in seven m
World medicine December 13,2023
Prostate cancer: The basics every man needs to know

Prostate cancer: The basics every man needs to know

by Miriam Jones Bradley, RNNo man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated.Prostate cancer affects one in seven m
World medicine December 13,2023
Give and take: Cancer chromosomes give the game away

Give and take: Cancer chromosomes give the game away

byQueensland University of TechnologyCredit: Queensland University of TechnologyDr. Pascal Duijf from QUT's School of Biomedical Sciences and IHBI (Institute of Health and Biomedical Innovat
World medicine December 13,2023
Give and take: Cancer chromosomes give the game away

Give and take: Cancer chromosomes give the game away

byQueensland University of TechnologyCredit: Queensland University of TechnologyDr. Pascal Duijf from QUT's School of Biomedical Sciences and IHBI (Institute of Health and Biomedical Innovat
World medicine December 13,2023
Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment

Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe patient-reported outcomes (PROs) of the phase 3 NRG Oncology clinical trial RTOG 0815 comparing dose-escalated radiotherapy (RT) alone to dose-escal
World medicine December 13,2023
Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment

Patients in clinical trial for prostate cancer report no decline in quality of life at one year post-treatment

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe patient-reported outcomes (PROs) of the phase 3 NRG Oncology clinical trial RTOG 0815 comparing dose-escalated radiotherapy (RT) alone to dose-escal
World medicine December 13,2023
New technique allows scientists to 'listen in' on cancer cells

New technique allows scientists to 'listen in' on cancer cells

byCancer Research UKElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteScientists have a developed a new technique to decipher how millions of i
World medicine December 13,2023
New technique allows scientists to 'listen in' on cancer cells

New technique allows scientists to 'listen in' on cancer cells

byCancer Research UKElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteScientists have a developed a new technique to decipher how millions of i
World medicine December 13,2023
Researchers take step toward automating thyroid cancer triage

Researchers take step toward automating thyroid cancer triage

byAmerican Roentgen Ray SocietyScreen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electron
World medicine December 13,2023
Researchers take step toward automating thyroid cancer triage

Researchers take step toward automating thyroid cancer triage

byAmerican Roentgen Ray SocietyScreen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electron
World medicine December 13,2023
Young men unaware of risks of HPV infection and need for HPV vaccination

Young men unaware of risks of HPV infection and need for HPV vaccination

byRutgers UniversityHPV is particularly concerning for sexual minority men due to the high prevalence of HIV and smoking in this community and the low HPV vaccination rates overall among men. Cr
World medicine December 13,2023
Young men unaware of risks of HPV infection and need for HPV vaccination

Young men unaware of risks of HPV infection and need for HPV vaccination

byRutgers UniversityHPV is particularly concerning for sexual minority men due to the high prevalence of HIV and smoking in this community and the low HPV vaccination rates overall among men. Cr
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com